Directions of optimization of information providing of pharmaceutical prophylaxis care for arterial hypertension
Journal Title: Фармацевтичний журнал - Year 2019, Vol 1, Issue 1
Abstract
Improvement of informational providing of pharmaceutical prevention care, especially in arterial hypertension, is the main direction for prevention of rational drug use. It was established that only 33% of patients with arterial hypertension control the level of arterial pressure within the limits of norm, and provision of pharmaceutical care will help to achieve the optimal level of blood pressure, increasing the persistence to the use of drugs and improve quality of life. The aim of the work. The aim was to justify the directions of informational providing of pharmaceutical prevention care of drug prescription for arterial hypertension treatment in implementation of “Affordable Drug Program” for improving data in current provisor (pharmacist) protocol. The study was conducted on the basis of current legislative acts approved in Ukraine and European guidelines for the treatment of arterial hypertension, as well as publications in the evidence-based basis on October 2018. The following research methods were used: systemic, analytical, content-analysis. We analyzed the data of European recommendations 2018 (ESH/ESC) and defined new factors influencing the development of cardiovascular diseases. We also examined the evidence in drugs for prevention of arterial hypertension and the most rational choice of drugs for an individual patient, taking into consideration the concomitant status. We reviewed as well the range of drugs for treatment of arterial hypertension, included in the regulatory lists of Ukraine that are in need of pharmaceutical prevention care. We presented the main interactions of inhibitor angiotensin II receptors. In order to improve the pharmacotherapy of patients the provisors (pharmacists) may use this information for warning about undesired interactions and side effects. We analyzed the pharmacist protocol for prescribing of prescription drugs for treatment of people with hypertension diseases, the cost of which are partially reimbursed. We showed that this protocol needs some basic additional information about both the primary prevention and the drugs such as angiotensin II receptor blockers and diuretics for a rational prescription and use of these medications. The system of information support of pharmaceutists on the rational use of drugs with arterial hypertension is substantiated.
Authors and Affiliations
G. Yu. Yatskova, N. M. Maksymovych, O. M. Zaliska
Keywords
Related Articles
- EP ID EP551920
- DOI 10.32352/0367-3057.1.19.03
- Views 59
- Downloads 0
Anticonvulsant activity of 5-(furan-2-yl)-4R1-1,2,4-triazole-3-thione S-derivatives
Among the huge number of drugs registered in Ukraine anticonvulsants occupy a special place. They are mainly used for the relief of different etiology seizures. Along with the principal pharmacological action of drugs in...
Pharmaceutical law and implementation of the United Nations Single convention on narcotic drugs of 1961 in the Republic of Tajikistan
After gaining independence in 1991 the Republic of Tajikistan has encountered a whole number of social, economic and political problems, illicit trafficking of narcotic drugs represents the greatest danger among them tha...
Component composition essential oils herbs sonchus oleraceus (Sonchus oleraceus L.) using gas chromatography mac-detection
Phytochemical studies of plants native flora to explore the possibilities of the complex use of raw materials creation on its basis of new drugs has recently become a significant date. This is due to the high efficiency...
Analysis of evidence-based information about herbal medicines used for treatment of pregnancy
WHO adopted the "Strategy traditional medicine: 2014-2013", that provides the development of databases (knowledge base) of traditional herbal medicines for use in national Drug policy. The goal of this article was to...
Comparative analysis of antimicrobial drugs recommended by medical and technological documents for the treatment of patients with community-acquired pneumonia
Today community-acquired pneumonia remains one of the leading causes of death as a result of infectious diseases. For effective treatment must be guided by such guidelines which would take into account not only recent wo...